Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study questions hypothermia treatment for cardiac arrest

19.11.2013
Therapeutic hypothermia – cooling the body and brain down to 33°C – is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects. However, keeping the temperature steady at 36°C is just as effective, a study led by Lund University researchers has found.

"Our results show that it is just as effective – both for survival and recovery of neurological function – to focus on avoiding the fever that accompanies cardiac arrest. We don't need to cool down the body and brain to 33°C. This is of course important because cooling to lower temperatures brings a higher risk of infection, bleeding and other side-effects", said Niklas Nielsen, researcher at Lund University and first author of the study.

Patients who come into hospital in cardiac arrest receive intensive care with cooling and ventilator treatment. Around half of them survive. Daily life goes quite well for those who survive, but around 30 per cent of cardiac arrest patients suffer impaired cognitive function, for example poorer memory.

"Until now, there has not been a clear place in the health service for the rehabilitation of these patients and one of our most important tasks is to identify them and tailor rehabilitation treatment to them. The median age for cardiac arrest is just over 60, and there are quite a lot of younger people who are affected. Rehabilitation can mean the difference between being able to go back to work and remaining on sick leave", said Niklas Nielsen.

The researchers are planning to analyse the patient data in more detail to see if there may be groups of patients for whom cooling could be beneficial and whether it has an impact at a more detailed cognitive level.

About the study:

The new research results are based on 10 years of data collection that has culminated in the study presented today – the largest international clinical study on patients ever. It has been carried out at 36 hospitals in 10 countries in Europe and in Australia, and includes 950 patients between 2010 and 2013. The main objective of the study was to investigate the optimal temperature for hypothermia treatment of patients in cardiac arrest, and to investigate the neurological function and quality of life of survivors after discharge from hospital.

The study was led by researchers from Lund University, Helsingborg Hospital and Skåne University Hospital – Niklas Nielsen, Hans Friberg, Tobias Cronberg and David Erlinge – together with an international steering group.

The research project has involved strong collaboration with Rigshospitalet in Copenhagen and has resulted in the establishment of a joint centre by Lund University, Skåne University Hospital, Helsingborg Hospital and Region Huvudstaden in Copenhagen.

Publication:

'Targeted Temperature Management Cardiac Arrest', New England Journal of Medicine

Niklas Nielsen, Jørn Wetterslev, Tobias Cronberg, David Erlinge, Yvan Gasche, Christian Hassager, Janneke Horn, Jan Hovdenes, Jesper Kjaergaard, Michael Kuiper, Tommaso Pellis, Pascal Stammet, Michael Wanscher, Matt P. Wise, Anders Åneman, Nawaf Al-Subaie, Søren Boesgaard, John Bro-Jeppesen, Iole Brunetti, Jan Frederik Bugge, Christopher D. Hingston, Nicole P. Juffermans, Matty Koopmans, Lars Køber, Jørund Langørgen, Gisela Lilja, Jacob Eifer Møller, Malin Rundgren, Christian Rylander, Ondrej Smid, Christophe Werer, Per Winkel, and Hans Friberg for the TTM Trial Investigators

Background:

The origin of the extensive study is the criticism of the two studies that was made when they were first published in 2002. The criticism that was made, with which Niklas Nielsen and his colleagues in Lund agree, was that:
the method was not sufficiently tested on a large number of patients and in different patient groups

no assessment was made of whether the effect of the treatment was due to the removal of the fever or to the cooling itself

The results have been presented today in the New England Journal of Medicine, and at the American Heart Association meeting in Dallas.

Contact:

Niklas Nielsen, consultant and researcher, Lund University
+46 708 89 97 70
Niklas.Nielsen@med.lu.se
WATCH VIDEO STORY: http://bit.ly/1jhaNg8

Niklas Nielsen | EurekAlert!
Further information:
http://www.lu.se

Further reports about: Medicine cardiac arrest neurological function

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>